author-photo

Philippe Follana

University of Nice Sophia Antipolis

91

Papers

895

Citations

Citation Trend

Filter By

Papers (69) Sort By

Journal Conference Others

741P Immune features of high-grade ovarian cancer associated with exceptional disease free survival (DFS): An analysis from VIVROVAIRE, a GINECO/GINEGEPS study

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
1032 Strong association between pathological response to neoadjuvant chemotherapy, TILs and modeled CA125 KELIM in ovarian carcinomas: CHIVA trial, GINECO

2021
Show All
- Source
- Cite
- Save
Citations (0)
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.

2021 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-13-05: Dolaf- an international multicenter phase 2 trial of durvalumab (medi4736) plus olaparib plus fulvestrant in metastatic or locally advanced er-positive, her2-negative breast cancer patients selected using criteria that predict sensitivity to olaparib (UCBG308)

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
CA-125 ELIMination rate constant K (KELIM) Is A Marker Of Chemosensitivity In Patients With Ovarian Cancer: Results from the Phase II CHIVA trial.

2020 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (7)
Evaluation of an individualized starting dose of niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

2020
Show All
- Source
- Cite
- Save
Citations (2)
17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial

2020
Show All
- Source
- Cite
- Save
Citations (0)
Allergy evaluation of hypersensitivity to platinium salts and taxanes: a six-year experience.

2020 The Journal of Allergy and Clinical Immunology: In Practice
Show All
- Source
- Cite
- Save
Citations (11)
294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial

2020
Show All
- Source
- Cite
- Save
Citations (1)